Zimmer Biomet Holdings, Inc. (ZBH)ZBHZimmer Biomet Holdings, Inc.

Balance Sheet

Assets, liabilities, and equity analysis

Quarterly Balance Sheet (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Total Current Assets	4.96B	4.96B	5.12B	5.83B	5.05B	5.59B	4.67B	4.86B	4.64B
Cash & Cash Equivalents	424.20M	424.20M	591.90M	1.29B	556.90M	1.38B	525.50M	569.00M	420.10M
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	424.20M	424.20M	591.90M	1.29B	556.90M	1.38B	525.50M	569.00M	420.10M
Accounts Receivable	1.73B	1.73B	1.70B	1.60B	1.61B	1.53B	1.48B	1.48B	1.42B
Inventory	2.25B	2.25B	2.29B	2.48B	2.45B	2.24B	2.24B	2.37B	2.37B
Total Assets	22.72B	22.72B	23.09B	23.49B	22.87B	22.18B	21.37B	21.72B	21.52B
Property, Plant & Equipment	2.21B	2.21B	2.21B	2.19B	2.18B	2.06B	2.05B	2.11B	2.10B
Goodwill	9.93B	9.93B	9.95B	9.70B	9.71B	8.99B	8.95B	8.91B	8.82B
Intangible Assets	4.55B	4.55B	4.72B	4.74B	4.89B	4.47B	4.60B	4.67B	4.71B
Long-Term Investments	22.30M	22.30M	39.40M	75.30M	32.20M	90.10M	73.20M	64.40M	99.10M
Total Current Liabilities	2.86B	2.86B	2.58B	2.40B	2.70B	2.29B	2.45B	3.57B	3.61B
Accounts Payable	361.20M	361.20M	303.00M	315.30M	348.70M	301.30M	194.60M	322.40M	341.80M
Short-Term Debt	1.18B	1.18B	587.10M	600.00M	820.00M	600.00M	863.00M	1.71B	1.88B
Total Liabilities	10.04B	10.04B	10.39B	10.72B	10.33B	9.78B	8.89B	9.34B	8.77B
Long-Term Debt	6.30B	6.30B	6.93B	7.51B	6.75B	6.58B	5.34B	4.74B	3.96B
Total Debt	7.47B	7.47B	7.52B	8.11B	7.57B	7.18B	6.20B	6.45B	5.83B
Net Debt (Cash)	7.05B	7.05B	6.93B	6.82B	7.02B	5.79B	5.68B	5.88B	5.41B
Total Shareholders' Equity	12.67B	12.67B	12.70B	12.76B	12.53B	12.40B	12.47B	12.37B	12.74B
Common Stock	3.20M	3.20M	3.20M	3.20M	3.20M	3.20M	3.20M	3.20M	3.20M
Retained Earnings	11.80B	11.80B	11.61B	11.52B	11.34B	11.23B	11.10B	10.90B	10.70B
Current Ratio	1.73	1.73	1.98	2.43	1.87	2.44	1.91	1.36	1.29
Debt to Equity Ratio	0.59	0.59	0.59	0.64	0.60	0.58	0.50	0.52	0.46

Annual Balance Sheet (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Current Assets	5.12B	4.67B	4.61B	4.43B	4.88B	5.08B	4.72B	4.43B
Cash & Cash Equivalents	591.90M	525.50M	415.80M	375.70M	378.10M	802.10M	617.90M	542.80M
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	591.90M	525.50M	415.80M	375.70M	378.10M	802.10M	617.90M	542.80M
Accounts Receivable	1.70B	1.48B	1.44B	1.38B	1.26B	1.45B	1.36B	1.28B
Inventory	2.29B	2.24B	2.39B	2.15B	2.15B	2.45B	2.38B	2.26B
Total Assets	23.09B	21.37B	21.50B	21.07B	23.46B	24.42B	24.64B	24.13B
Property, Plant & Equipment	2.21B	2.05B	2.06B	1.87B	1.84B	2.05B	2.08B	2.02B
Goodwill	9.95B	8.95B	8.82B	8.58B	8.92B	9.26B	9.60B	9.59B
Intangible Assets	4.72B	4.60B	4.86B	5.06B	5.53B	7.06B	7.26B	7.68B
Long-Term Investments	39.40M	73.20M	31.60M	16.60M	27.60M	0.00	0.00	0.00
Total Current Liabilities	2.58B	2.45B	2.86B	2.36B	3.47B	2.56B	3.44B	2.42B
Accounts Payable	303.00M	194.60M	410.60M	354.10M	306.50M	330.00M	400.90M	362.60M
Short-Term Debt	587.10M	863.00M	900.00M	544.30M	1.61B	500.00M	1.50B	525.00M
Total Liabilities	10.39B	8.89B	9.01B	9.04B	10.79B	12.22B	12.25B	12.85B
Long-Term Debt	6.93B	5.34B	4.87B	5.15B	5.46B	7.63B	6.72B	8.41B
Total Debt	7.52B	6.20B	5.77B	5.70B	7.07B	8.13B	8.22B	8.94B
Net Debt (Cash)	6.93B	5.68B	5.35B	5.32B	6.69B	7.32B	7.60B	8.40B
Total Shareholders' Equity	12.70B	12.47B	12.48B	12.02B	12.66B	12.19B	12.39B	11.27B
Common Stock	3.20M	3.20M	3.20M	3.10M	3.10M	3.10M	3.10M	3.10M
Retained Earnings	11.61B	11.10B	10.38B	9.56B	10.29B	10.09B	10.43B	9.49B
Current Ratio	1.98	1.91	1.61	1.88	1.41	1.99	1.37	1.83
Debt to Equity Ratio	0.59	0.50	0.46	0.47	0.56	0.67	0.66	0.79

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Warsaw, IN

17,000 employees

www.zimmerbiomet.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Ivan Tornos

View full financials

Quarterly Report

TTM

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Quarter ended Jun 2024

Total Current Assets

4.96B

5.12B

5.83B

5.05B

5.59B

4.67B

4.86B

4.64B

Cash & Cash Equivalents

424.20M

591.90M

1.29B

556.90M

1.38B

525.50M

569.00M

420.10M

Short-Term Investments

0.00

Cash & Short-Term Investments

424.20M

591.90M

1.29B

556.90M

1.38B

525.50M

569.00M

420.10M

Accounts Receivable

1.73B

1.70B

1.60B

1.61B

1.53B

1.48B

1.42B

Inventory

2.25B

2.29B

2.48B

2.45B

2.24B

2.37B

Total Assets

22.72B

23.09B

23.49B

22.87B

22.18B

21.37B

21.72B

21.52B

Property, Plant & Equipment

2.21B

2.19B

2.18B

2.06B

2.05B

2.11B

2.10B

Goodwill

9.93B

9.95B

9.70B

9.71B

8.99B

8.95B

8.91B

8.82B

Intangible Assets

4.55B

4.72B

4.74B

4.89B

4.47B

4.60B

4.67B

4.71B

Long-Term Investments

22.30M

39.40M

75.30M

32.20M

90.10M

73.20M

64.40M

99.10M

Total Current Liabilities

2.86B

2.58B

2.40B

2.70B

2.29B

2.45B

3.57B

3.61B

Accounts Payable

361.20M

303.00M

315.30M

348.70M

301.30M

194.60M

322.40M

341.80M

Short-Term Debt

1.18B

587.10M

600.00M

820.00M

600.00M

863.00M

1.71B

1.88B

Total Liabilities

10.04B

10.39B

10.72B

10.33B

9.78B

8.89B

9.34B

8.77B

Long-Term Debt

6.30B

6.93B

7.51B

6.75B

6.58B

5.34B

4.74B

3.96B

Total Debt

7.47B

7.52B

8.11B

7.57B

7.18B

6.20B

6.45B

5.83B

Net Debt (Cash)

7.05B

6.93B

6.82B

7.02B

5.79B

5.68B

5.88B

5.41B

Total Shareholders' Equity

12.67B

12.70B

12.76B

12.53B

12.40B

12.47B

12.37B

12.74B

Common Stock

3.20M

Retained Earnings

11.80B

11.61B

11.52B

11.34B

11.23B

11.10B

10.90B

10.70B

Current Ratio

1.73

1.98

2.43

1.87

2.44

1.91

1.36

1.29

Debt to Equity Ratio

0.59

0.64

0.60

0.58

0.50

0.52

0.46

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Total Current Assets

5.12B

4.67B

4.61B

4.43B

4.88B

5.08B

4.72B

4.43B

Cash & Cash Equivalents

591.90M

525.50M

415.80M

375.70M

378.10M

802.10M

617.90M

542.80M

Short-Term Investments

0.00

Cash & Short-Term Investments

591.90M

525.50M

415.80M

375.70M

378.10M

802.10M

617.90M

542.80M

Accounts Receivable

1.70B

1.48B

1.44B

1.38B

1.26B

1.45B

1.36B

1.28B

Inventory

2.29B

2.24B

2.39B

2.15B

2.45B

2.38B

2.26B

Total Assets

23.09B

21.37B

21.50B

21.07B

23.46B

24.42B

24.64B

24.13B

Property, Plant & Equipment

2.21B

2.05B

2.06B

1.87B

1.84B

2.05B

2.08B

2.02B

Goodwill

9.95B

8.95B

8.82B

8.58B

8.92B

9.26B

9.60B

9.59B

Intangible Assets

4.72B

4.60B

4.86B

5.06B

5.53B

7.06B

7.26B

7.68B

Long-Term Investments

39.40M

73.20M

31.60M

16.60M

27.60M

0.00

Total Current Liabilities

2.58B

2.45B

2.86B

2.36B

3.47B

2.56B

3.44B

2.42B

Accounts Payable

303.00M

194.60M

410.60M

354.10M

306.50M

330.00M

400.90M

362.60M

Short-Term Debt

587.10M

863.00M

900.00M

544.30M

1.61B

500.00M

1.50B

525.00M

Total Liabilities

10.39B

8.89B

9.01B

9.04B

10.79B

12.22B

12.25B

12.85B

Long-Term Debt

6.93B

5.34B

4.87B

5.15B

5.46B

7.63B

6.72B

8.41B

Total Debt

7.52B

6.20B

5.77B

5.70B

7.07B

8.13B

8.22B

8.94B

Net Debt (Cash)

6.93B

5.68B

5.35B

5.32B

6.69B

7.32B

7.60B

8.40B

Total Shareholders' Equity

12.70B

12.47B

12.48B

12.02B

12.66B

12.19B

12.39B

11.27B

Common Stock

3.20M

3.10M

Retained Earnings

11.61B

11.10B

10.38B

9.56B

10.29B

10.09B

10.43B

9.49B

Current Ratio

1.98

1.91

1.61

1.88

1.41

1.99

1.37

1.83

Debt to Equity Ratio

0.59

0.50

0.46

0.47

0.56

0.67

0.66

0.79